Company profile

Indivior Pharmaceuticals, Inc. Insider Trading

INDV

Every SEC Form 4 insider trading filing for Indivior Pharmaceuticals, Inc. (INDV) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
CIK
0001625297
Filings
38
Insiders
13
Last filing
2026-08-05

Activity summary

Recent insider activity is bullish. Over the last 30 days, 1 insider purchased shares (net $54K). Buying was led by Anderson Woodrow D.

Quarterly balance

Buy and sell value by quarter, Q1 26 to Q3 26. Indivior Pharmaceuticals, Inc. insiders were net sellers in every quarter shown.

Q1 26Q2 26Q3 26

Bars below the rule are sales, above are purchases. Largest quarter on the chart is $25.6M.

90 day insight

Over the last 90 days, Indivior Pharmaceuticals, Inc. insiders bought $54K (3 transactions) and sold $23.5M (1 transaction).

  • Most active insider: Ciaffoni Joseph with 3 transactions totaling $23.5M.
  • Largest single sale: $23.5M by Ciaffoni Joseph on Jun 22, 2026.
  • 75% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.

Activity skews bullish — buys outpace sales.

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Aug 5, 2026Anderson Woodrow DINDV
Purchase
1,500$36.28$54K
Jul 10, 2026Heidbreder ChristianINDV
Sale10b5
18,586$41.14$765K
Jun 22, 2026Ciaffoni JosephINDV
Option Exercise
1,266,903
Jun 22, 2026Ciaffoni JosephINDV
Tax Withholding
612,549$38.32$23.47M
Jun 22, 2026Ciaffoni JosephINDV
Option Exercise
1,266,903

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Query this yourself

The same rows, over the API.

curl "https://api.form4api.com/v1/transactions?ticker=INDV" \
  -H "X-Api-Key: $KEY"
Get a key

Top insiders

By total value filed.

Ciaffoni JosephChief Executive Officer1 filing$23.5M
Preblick RyanChief Financial Officer3 filings$4.2M
Heidbreder ChristianChief Scientific Officer3 filings$2.9M
Burris Jeffrey WChief Legal Officer1 filing$1.2M
Anderson Woodrow DChief Accounting Officer3 filings$296K

Institutional Ownership

Top 13F-HR holders of Indivior Pharmaceuticals, Inc. as of 2026-06-30

↓ decreasing
Total reported AUM
$1.31B
QoQ change
-62.6%
Reporting period
2026-06-30
#1
BlackRock, Inc.
CIK 0002012383
$550.7M
13.4M shares
#2
State Street Corp
CIK 0000093751
$204.8M
5.0M shares
#3
BlackRock, Inc.
CIK 0002012383
$153.0M
3.7M shares

Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →